Pallozzi, Maria
 Distribuzione geografica
Continente #
EU - Europa 106
AS - Asia 99
NA - Nord America 88
SA - Sud America 19
AF - Africa 6
Totale 318
Nazione #
US - Stati Uniti d'America 83
IT - Italia 44
SG - Singapore 40
CN - Cina 30
BR - Brasile 17
FR - Francia 17
DE - Germania 14
SE - Svezia 13
IN - India 12
ID - Indonesia 6
FI - Finlandia 5
IE - Irlanda 5
KR - Corea 5
CA - Canada 4
TZ - Tanzania 4
AT - Austria 2
GB - Regno Unito 2
JP - Giappone 2
MA - Marocco 2
AR - Argentina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
NL - Olanda 1
PA - Panama 1
PE - Perù 1
RU - Federazione Russa 1
Totale 318
Città #
Singapore 27
Rome 16
Ashburn 10
Chandler 10
Hyderabad 8
New York 8
Arezzo 7
Hefei 7
Boardman 6
Jakarta 6
The Dalles 6
Dublin 5
Frankfurt am Main 5
Seoul 5
Düsseldorf 4
Milan 4
Dar es Salaam 3
Lauterbourg 3
North Bergen 3
Nuremberg 3
São Paulo 3
Beijing 2
Chicago 2
Genoa 2
Lappeenranta 2
Los Angeles 2
Paris 2
Pune 2
Tokyo 2
Toronto 2
Turku 2
Vigevano 2
Almaty 1
Arapongas 1
Bexley 1
Biguaçu 1
Boston 1
Bremen 1
Brno 1
Buenos Aires 1
Catania 1
Council Bluffs 1
Diadema 1
Duhok 1
Florianópolis 1
Helsinki 1
Hong Kong 1
Itirapina 1
Lagarto 1
Leawood 1
Lima 1
Lishui 1
Marabá 1
Marialva 1
Moscow 1
Mumbai 1
Munich 1
Nanjing 1
Naples 1
Newark 1
Ottawa 1
Pelotas 1
Phnom Penh 1
Portsmouth 1
Princeton 1
Rio de Janeiro 1
Roggiano Gravina 1
Salvador 1
San Francisco 1
São Carlos 1
São José do Rio Preto 1
Teófilo Otoni 1
Vancouver 1
Vienna 1
Yiwu 1
Totale 214
Nome #
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma 57
Cellular therapies in liver and pancreatic diseases 41
SIRT in 2025 36
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 33
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 33
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives 33
The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogene-sis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus 27
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 24
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis 19
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 19
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 7
Totale 329
Categoria #
all - tutte 2.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 0 0 0 0 0 0 0 2 3
2022/202336 3 4 2 3 5 1 0 11 5 0 0 2
2023/202465 7 9 2 1 3 12 3 1 1 7 9 10
2024/2025223 4 3 26 6 13 16 19 6 26 36 62 6
Totale 329